[1] |
LI Shuran, GUO Shanshan, JI Zuen, ZHANG Wei, CUI Xiaolan.
Research status of cognitive dysfunction after SARS-CoV-2 infection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 59-64.
|
[2] |
CHEN Cheng, DENG Li, LIU Songqing, DU Qian, XI Xin.
Analysis of reports of allergic shock in Chongqing between 2015 and 2020
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 460-464.
|
[3] |
LIU Baohua, SHEN Aizong, SU Dan.
Pharmaceutical care for a case of severe myelosuppression induced by meropenem injection combined with vancomycin injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 339-342.
|
[4] |
JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong.
Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
|
[5] |
ZHANG Jingyu, ZHANG Yuanyuan, WANG Jing, MA Bo, LI Wenjuan.
Influencing factors of severe anaphylactic reactions of Yanhuning injections in children
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1019-1022.
|
[6] |
HOU Tiantian, LI Xuejiao, SUN Lei, QIN Chao, ZHAO Jing, HUO Yan, WANG Yu, GENG Xingchao, HUANG Ying.
Biodistribution study of CAR-T cells in non-bearing-tumor and tumor-bearing severe immunodeficient mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 823-827.
|
[7] |
FU Hong, RONG Youhe.
One Case of Severe Adverse Drug Reactions Induced by rt-PA and Literature Analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1198-1200.
|
[8] |
YOU Cuiyu, XU Xiaoli, LI Sha, XUE Siyu, CHEN Siying, WANG Maoyi.
140 Cases of Severe Adverse Drug Reactions/Events in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 617-621.
|
[9] |
PANG Wenyuan, WANG Qiaoyu, ZHAO Zhigang.
Application and Evaluation of Arbidol in Treating Viral Diseases
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 321-325.
|
[10] |
LI Wen-wu.
Analysis of 102 Reports of ADR/ADE Induced by Posterior Pituitary Injection
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(4): 232-234.
|
[11] |
LIU Xian-jun.
Pharmaceutical Care for a Patient with Severe Pulmonary Infection by Clinical Pharmacist
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(2): 117-119.
|
[12] |
XU Shun-gui ,ZHAO Shang-qing ,WANG Yong-hong.
Literature Analysis of 171 Cases of Severe Adverse Drug Reactions in Children
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(7): 427-431.
|
[13] |
LI Wen-wu .
Analysis of 157 Reports of ADR/ADE Induced by Magnesium Sulfate Injection
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(12): 737-739.
|
[14] |
CHEN Hai-yun.
Analysis of 474 Adverse Drug Reaction/Event Cases Induced by Anticancer Drugs
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(11): 676-678.
|
[15] |
FAN Ping-ping.
Analysis of 42 Cases of Adverse Reactions Caused by Kitasamycin for Injection
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 244-246.
|